Additionally, increased levels of BM CD8+ T-cells from relapsing AML patients expressing TIM-3, PD-1 and CTLA-4, have been reported, while their corresponding ligands Gal-9, PDL-1, CD80, and CD86 were expressed on leukemic blasts [55]. This evidence concerns the gene LGALS9 and acute myeloid leukemia.